StockNews.com started coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a report published on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also recently commented on ACRX. HC Wainwright reaffirmed a buy rating and set a $5.00 price objective on shares […]
StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note released on Friday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. A number of other research analysts also recently issued reports on the company. Alliance Global Partners initiated coverage on AcelRx Pharmaceuticals in a research […]
StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note issued to investors on Friday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. ACRX has been the topic of a number of other reports. HC Wainwright reaffirmed a buy rating and set a $5.00 target […]
StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note released on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. AcelRx Pharmaceuticals Trading Down 5.5 % Shares of ACRX stock opened at $1.21 on Friday. The company has a market capitalization of $13.21 […]
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX – Get Rating) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 860,000 shares, a growth of 12.3% from the May 15th total of 765,800 shares. Based on an average trading volume of 222,000 shares, the […]